Shanghai Yizhong Pharmaceutical Co Ltd (688091) — Cash Flow Reinvestment Rate
Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Cash Flow Reinvestment Rate of 1.44x as of September 2025, reinvesting CN¥30.36 Million (capex CN¥30.36 Million ) from operating cash flow of CN¥21.03 Million. Explore Shanghai Yizhong Pharmaceutical Co Ltd (688091) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Yizhong Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2022–2024)
Historical reinvestment intensity for Shanghai Yizhong Pharmaceutical Co Ltd across 3 annual periods. Also explore 688091 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shanghai Yizhong Pharmaceutical Co Ltd (2022–2024)
Year-by-year capital reinvestment analysis for Shanghai Yizhong Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 688091 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.60x | CN¥102.42 Million | CN¥39.44 Million | CN¥80.04 Million | ▲ +367.8% |
| 2023 | 0.56x | CN¥48.06 Million | CN¥86.55 Million | CN¥8.78 Million | ▼ -88.6% |
| 2022 | 4.86x | CN¥538.15 Million | CN¥110.78 Million | CN¥35.88 Million | — |